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ABSTRACT
OBJECTIVE
To determine whether bicycle commuting is 
associated with risk of injury.
DESIGN
Prospective population based study.
SETTING
UK Biobank.
PARTICIPANTS
230 390 commuters (52.1% women; mean age 52.4 
years) recruited from 22 sites across the UK compared 
by mode of transport used (walking, cycling, mixed 
mode versus non-active (car or public transport)) to 
commute to and from work on a typical day.
MAIN OUTCOME MEASURE
First incident admission to hospital for injury.
RESULTS
5704 (2.5%) participants reported cycling as 
their main form of commuter transport. Median 
follow-up was 8.9 years (interquartile range 8.2-
9.5 years), and overall 10 241 (4.4%) participants 
experienced an injury. Injuries occurred in 397 (7.0%) 
of the commuters who cycled and 7698 (4.3%) of 
the commuters who used a non-active mode of 
transport. After adjustment for major confounding 
sociodemographic, health, and lifestyle factors, 
cycling to work was associated with a higher risk of 
injury compared with commuting by a non-active 
mode (hazard ratio 1.45, 95% confidence interval 
1.30 to 1.61). Similar trends were observed for 
commuters who used mixed mode cycling. Walking to 
work was not associated with a higher risk of injury. 
Longer cycling distances during commuting were 
associated with a higher risk of injury, but commute 
distance was not associated with injury in non-active 
commuters. Cycle commuting was also associated 
with a higher number of injuries when the external 
cause was a transport related incident (incident rate 
ratio 3.42, 95% confidence interval 3.00 to 3.90). 
Commuters who cycled to work had a lower risk of 
cardiovascular disease, cancer, and death than 
those who did not. If the associations are causal, an 
estimated 1000 participants changing their mode of 
commuting to include cycling for 10 years would result 
in 26 additional admissions to hospital for a first 
injury (of which three would require a hospital stay 
of a week or longer), 15 fewer first cancer diagnoses, 
four fewer cardiovascular disease events, and three 
fewer deaths.
CONCLUSION
Compared with non-active commuting to work, 
commuting by cycling was associated with a higher 
risk of hospital admission for a first injury and higher 
risk of transport related incidents specifically. These 
risks should be viewed in context of the health 
benefits of active commuting and underscore the need 
for a safer infrastructure for cycling in the UK.
Introduction
A large and consistent evidence base from prospective 
cohort studies suggests that regular physical activity 
is associated with many positive health outcomes, 
including a lower risk of mortality and lower incidence 
of cardiovascular disease, stroke, hypertension, type 
2 diabetes, and some cancers (principally breast and 
colon).1-4 Despite this, 20 million adults in the UK 
are failing to meet government recommendations for 
physical activity (≥150 minutes of moderate physical 
activity weekly), increasing their risk of heart disease 
and costing the UK health service as much as £1.2bn 
($1.6bn; €1.4bn) each year.5 One way in which people 
can incorporate physical activity into their day is 
to use an active mode of commuting,6-9 and recent 
evidence has shown that active modes of commuting, 
including cycling, result in improved fitness and lower 
adiposity10 and are associated with a lower risk of 
cardiovascular disease, cancer, type 2 diabetes, and all 
cause mortality.11-15
Despite the apparent benefits of cycling, the number 
of people commuting by bicycle in the UK and many 
other countries is low.16 The British Social Attitudes 
survey of adults (≥18 years) suggests that only 4% of 
people cycle to work once a week despite 39% owning 
a bicycle, and 64% of respondents agreed or strongly 
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WHAT IS ALREADY KNOWN ON THIS TOPIC
Cycling commuting has been associated with a lower risk of morbidity and 
mortality
A key barrier to the uptake of commuter cycling among the public includes 
perceived and objective traffic danger
Individual level evidence on cycling and injuries is, however, limited
WHAT THIS STUDY ADDS
Our study suggests that commuting by cycling is associated with a 45% higher 
risk of admission to hospital for an injury and 3.4-fold higher risk of a transport 
related injury
Commuting longer distances by cycling is associated with a higher risk of injury 
than shorter distances, whereas distance was not associated with injury rate in 
non-active commuters
If 1000 participants changed their mode of commuting to include cycling for 10 
years, this would translate into an estimated additional 26 hospital admissions 
for a first injury (of which three would require a hospital stay of a week or longer), 
15 fewer first cancer diagnoses, four fewer cardiovascular disease events, and 
three fewer deaths
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agreed that cycling on roads is too dangerous.17 Indeed, 
a systematic review, including 21 observational studies 
from five countries that investigated the association 
between cycling infrastructure and levels of cycling 
reported on key barriers to cycling at environmental 
level, which included perceived and objective traffic 
related dangers.18 Evidence on cycling and injuries 
from the UK is limited and suggests that for cyclists 
the risks increase with age, whereas for young men, 
cycling has lower fatality rates per unit time travelling 
than driving.19 It is important to empirically validate 
the perception of the increased risk of injury among 
cyclists and what benefits might be expected from 
successful infrastructure interventions to promote 
safety. This information is pertinent to policy makers 
when devising strategies to improve public health 
through active commuting, by highlighting potential 
risks and to help realise greater benefits of increased 
active commuting in the UK general population.20
We used the UK Biobank cohort to investigate the 
association between bicycle commuting and risk 
of injury compared with other forms of commuting 
transport.
Methods
UK Biobank
The UK Biobank cohort includes 502 536 participants 
(aged 37-73 years, 54.4% women) recruited between 
2006 and 2010 from across the UK. Baseline 
assessments conducted at 22 assessment centres 
included a touch screen questionnaire covering an 
extensive range of health and lifestyle factors, a 
computer assisted verbal interview, a wide range of 
physical tests, and collection of several biological 
samples. This information was then linked, with 
permission, to death records. We obtained the date 
and cause of death from death certificates held by 
the National Health Service Information Centre for 
participants from England and Wales and the NHS 
Central Register Scotland for participants from 
Scotland. Baseline data were also linked to hospital 
episode statistics data. Further details on procedures 
and sample analyses can be found in the UK Biobank 
online showcase and protocol (www.ukbiobank.ac.uk).
Measurement of exposures
We excluded participants who had not provided 
information on their commute, did not work 
(n=238 263), reported highly unrepresentative 
commuting distances (>200 miles per journey), 
reported commuting more than 12 times a week 
(n=18 031), or had missing data for covariates 
(n=15 312). Participants who reported commuting to 
work less than once a week were assigned a value of 
0.5 for frequency of commuting, those who reported 
a commute distance of less than 1 mile (1.6 km) were 
assigned a value of 0.5 miles, and those who reported 
a rounded zero miles between home and workplace 
were assigned a value of 0.3 miles. At baseline we 
used the mode of transportation from an electronic 
questionnaire with response to the question: “In a 
typical day, what types of transport do you use to get to 
and from work?” Responders could select one or more 
of: car/motor vehicle, walk, public transport, and cycle. 
We derived five commuting categories: non-active (car/
motor vehicle or public transport), walking, cycling, 
mixed mode walking (non-active plus walking), and 
mixed mode cycling (cycling plus other modes). As 
such, the definition of commuters exclusively cycling 
to work is stricter in this paper than in previous work.11 
We also used a binary commuting variable in which 
people included or did not include cycling at all in 
their commute. The weekly commuting distance was 
derived from the single commuting distance multiplied 
by 2 to obtain a round trip distance and by the weekly 
number of round trips reported by the participant.
To account for each participant’s leisure time 
physical activity levels, we constructed a composite 
variable combining two exercise related variables 
(number of days doing 10 minutes or more of 
moderate physical activity each week, and similarly 
for vigorous activity) by first categorising both 
moderate and vigorous physical activity variables into 
three categories (0 days/week=0, 1-3 days/week=1, 
and >3 days/week=2) and then summing the resultant 
categories. Five levels of physical activity scores 
(score 0-4) were thereby derived. For presentation 
we summarised these levels as inactive (score=0), 
moderate (score=1-3), or active (score=4), but the five 
level score was used in adjustment models. Location of 
home area was used as a binary variable representing 
urban/town area, or other areas that were “rural” 
(village/hamlet/rural) according to postcode and the 
Deaths
Study design Cohort study
requiring a stay of ≥ week
requiring a stay of < week
Cardiovascular events
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Cycling to work was associated with a higher risk of injury. 
These risks should be viewed in context of the health benefits, 
and underscore the need for a safer cycling infrastructure
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Injury related hospital admissions for UK commuters
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2001 census national statistics. Body mass index 
(BMI) was categorised into underweight (<18.5 kg/
m2), normal weight (18.5-24.9), overweight (25-
29.9), and obese (≥30). Smoking status and alcohol 
consumption were self-reported. Presence of baseline 
cardiovascular disease was defined as self-reported 
“heart attack”, angina, or stroke. Baseline cancer, 
depression, and longstanding illness were also self-
reported. The presence of baseline diabetes was based 
on self-reported diabetes diagnosis or use of diabetes 
drugs. Hypertension was self-reported or identified 
from a baseline systolic blood pressure of >140 mm 
Hg or diastolic blood pressure >90 mm Hg.
Measurement of outcomes
As changes in mode of commuting might occur after an 
index injury, we used time to first event analysis in the 
primary model. The primary outcome of interest was 
any injury (international classification of diseases, 10th 
revision (ICD-10) codes S00-S99, T00-T14, V00-V99) 
that resulted in a first hospital admission in hospital 
episode statistics, or death with injury as the primary 
cause. Hospital admission data included diagnoses 
from emergency departments as well as from inpatient 
records. Further sensitivity analyses restricted the 
outcome to injuries of the arms or legs (appendicular, 
ICD-10 codes S40-S99), trunk (S20-S39), or head or 
neck (S00-S19), and fractures (S02, S12, S22, S32, 
S42, S52, S62, S72, S82, S92, S07, T02, T10, or T12). 
Follow-up for participants began at their baseline 
assessment and ended at their first recorded injury, 
the end of follow-up at the assessment centre (30 
November 2016 in Scotland and 31 January 2018 in 
England or Wales), or death, whichever came first. In 
all the groups, a proportion of the injuries will not be 
specifically due to mode of commuting, but the model 
assumes that excess risk of injury occurs as a result of 
differences in commuting between groups.
In a secondary analysis we investigated injuries that 
were specifically coded as transport related incidents. 
As such, the outcome of interest was number of 
transport incidents per person in the external causes 
of hospital episode statistics (ICD-10 codes V00-V99) 
during follow-up. We also specifically investigated 
cycle related transport incidents in the external causes 
of hospital episode statistics (ICD-10 codes V10-V19) 
as an internal validation; those who reported 
commuting by cycling should have a greater number of 
cycle related transport incidents.
To place the injury data in context, we conducted a 
further analysis to investigate the association of mode 
of commuting with morbidity and mortality, updating 
previous work11 (the models reported here differ for 
defined commuting types and outcomes). Incident 
cardiovascular disease was defined as admission to 
hospital for myocardial infarction or stroke (ICD-10 codes 
I21, I22, I60-64) or death from cardiovascular disease 
(I20-I25; I60-I64) (primary cause), and incident cancer 
was defined as admission to hospital for cancer or death 
from cancer (primary cause) (codes C00-C99, D00-D48) 
among those who reported no previous cancer.
Statistical analyses
The distribution of baseline characteristics was 
investigated across commuting modes (non-active, 
walking, cycling, mixed mode walking, or mixed mode 
cycling), displayed as means (standard deviations) 
if normal, medians (interquartile ranges) if skewed, 
and numbers (percentages) if categorical. Tests of 
differences across modes were conducted by analysis 
of variance, Kruskal-Wallis, and χ2, respectively.
For each group we calculated the incidence rate 
of first hospital episodes attributed to injury for 
each 10 000 miles commuted by dividing the mean 
number of injury related hospital admissions weekly 
(assuming six weeks of annual leave in a year) by 
the number of miles travelled each week (commute 
distance multiplied by 2 and by the number of days 
the participant commuted each week). The incidence 
rate of first injury related hospital admission per 1000 
person years was calculated using a simple counting 
method. To calculate the number of hours participants 
spent commuting, we used external data to model 
walking at 3.4 miles per hour (mph, 5.5 km/h), cycling 
at 8.3 mph (13.4 km/h), and driving at 27.6 mph (44.4 
km/h).19
We then investigated the association of injury with 
commuting mode using Cox proportional hazard 
models. Competing risks models were also investigated 
using non-cardiovascular disease related death as 
the competing risk, but as the hazard ratios were not 
meaningfully impacted we used the simpler model. 
Cox models were adjusted first for age and sex, then 
additionally for ethnicity, Townsend deprivation 
index score, comorbidities (longstanding self-
reported illness, diabetes, hypertension, baseline 
cardiovascular disease, previous cancer, and 
depression), BMI, smoking (never, former, current), 
alcohol drinker status (never, former, current), and 
five levels of physical activity. The proportional 
hazards assumption was checked by visual inspection 
of Schöenfeld residuals. The association of the 
commuting groups with the secondary outcomes of 
specific injury subtypes was modelled using a time to 
first event model for each injury subtype separately. We 
used the same models for outcomes of cardiovascular 
disease, cancer, and all cause mortality. The primary 
analyses were also stratified in six additional ways: by 
category of distance travelled (one way) on a typical 
commute, sex, residential area (urban/town versus 
rural), binary physical activity (moderate or low versus 
high), binary assessment date (before versus after 1 
January 2010), and length of hospital stay. Assessment 
dates that occur after January 2010 are intended to act 
as a proxy for provision of potentially improved cycling 
infrastructure in some areas after this date,21-23 which 
might reduce cycling associated injuries. Length of 
hospital stay is intended to act as a proxy for injury 
severity.
For the secondary outcome of transport incidents, we 
reported the mean number of events recorded for each 
participant over the follow-up time in each commuting 
group, and expressed these as mean events per 100 
 o
n
 12 M
arch 2020 at University of G
lasgow. Protected by copyright.
http://www.bmj.com/
BM
J: first published as 10.1136/bmj.m336 on 11 March 2020. Downloaded from 
RESEARCH
4 doi: 10.1136/bmj.m336 | BMJ 2020;368:m336 | the bmj
persons. A negative binomial model with constant 
dispersion, robust standard errors, and identical 
adjustment to the Cox models was utilised to obtain 
the incidence rate ratio of transport incidents by mode 
of commuting.24 We also applied the model to cycling 
related transport incidents. To calculate the adjusted 
absolute rate difference between cyclists and non-
cyclists for different outcomes, we firstly calculated 
the incidence rate of non-cyclists (base rate). The 
injury rate of cyclists was then estimated by applying 
incidence rate ratios from a negative binomial model 
(offsetting for logged follow-up time) onto the base rate. 
All analyses were conducted in STATA version 15.1.
Patient and public involvement
The UK Biobank resource included extensive 
public consultation in its design. No participants 
were involved in setting this research question or 
the outcome measures, nor were they involved in 
developing plans for design or implementation of 
the study. No participants were asked to advise on 
interpretation or writing up of results.
Results
Baseline characteristics
Of the 230 390 participants (52.1% women, mean 
age 52.4 years) who self-reported their commute 
type, 5704 (2.5%) reported exclusively cycling. 
Compared with non-active commuters (n=178 976, 
77.5%), cycle commuters were slightly younger, had 
a lower BMI, were more likely to be white men, and 
less likely to be a current smoker or have a history 
of cardiovascular disease, diabetes, cancer, or 
longstanding illness (table 1). They were also more 
likely to be physically active in leisure time (table 
1). Mixed mode commuter cyclists (n=13 380, 5.8%) 
also had a broadly healthier profile than non-active 
commuters.
Incidence of injury
Across all participants, the median follow-up time 
was 8.9 years (interquartile range 8.2-9.5 years), 
and 10 241 (4.4%) participants had at least one 
hospital admission for an injury or died with injury 
listed as the primary cause (n=29 died). Those who 
were injured were generally older and more likely to 
be white men and to be a current smoker and have 
a history of cardiovascular disease, diabetes, cancer, 
or longstanding illness (table 2). A trend was also 
observed whereby those injured were slightly more 
likely to be physically active, although BMI was not 
associated with injury (table 2).
Injuries were experienced by 397 (7.0%) of the 
participants who reported commuting by cycling 
Table 1 | Baseline characteristics of participants (n=230 930) by commuting category. Values are numbers (percentages) unless stated otherwise
Characteristics
Non-active 
(n=178 976)
Walk  
(n=12 352)
Cycle  
(n=5704)
Mixed mode: walk 
(n=20 518)
Mixed-mode: cycle 
(n=13 380)
Mean (SD) age (years) 52.6 (7.0) 52.9 (7.0) 51.4 (7.0) 52.3 (6.8) 50.3 (6.7)
Women 92 393 (51.6) 8413 (68.1) 1961 (34.4) 12 709 (61.9) 4754 (35.5)
Men 86 583 (48.4) 3939 (31.9) 3743 (65.6) 7809 (38.1) 8626 (64.5)
Ethnicity:
 White 169 649 (94.8) 11 733 (95.0) 5508 (96.6) 19 436 (94.7) 12 977 (97.0)
 Black 2862 (1.6) 160 (1.3) 44 (0.8) 334 (1.6) 113 (0.8)
 South Asian 2781 (1.6) 158 (1.3) 21 (0.4) 276 (1.3) 67 (0.5)
 Other 3684 (2.1) 301 (2.4) 131 (2.3) 472 (2.3) 223 (1.7)
Smoking status:
 Never 103 234 (57.7) 7207 (58.3) 3285 (57.6) 12 474 (60.8) 7875 (58.9)
 Former 56 620 (31.6) 3773 (30.5) 1878 (32.9) 6281 (30.6) 4388 (32.8)
 Current 19 122 (10.7) 1372 (11.1) 541 (9.5) 1763 (8.6) 1117 (8.3)
Baseline cardiovascular disease 5420 (3.0) 333 (2.7) 99 (1.7) 446 (2.2) 228 (1.7)
Median (interquartile range) Townsend 
deprivation index
−2.39 (−3.77, −0.10) −0.47 (−2.68, 2.31) −0.91 (−2.91, 1.80) −1.51 (−3.33, 1.15) −1.88 (−3.54, 0.62)
Longstanding illness 44 173 (24.7) 2832 (22.9) 1081 (19.0) 5034 (24.5) 2653 (19.8)
Physical activity:
 Sedentary 23 013 (12.9) 1228 (9.9) 4 (0.1) 2500 (12.2) 152 (1.1)
 Moderately active 128 897 (72.0) 8893 (72.0) 2192 (38.4) 15 488 (75.5) 8550 (63.9)
 Very active 27 066 (15.1) 2231 (18.1) 3508 (61.5) 2530 (12.3) 4678 (35.0)
Previous cancer 10 073 (5.6) 742 (6.0) 247 (4.3) 1120 (5.5) 606 (4.5)
Diabetes 6500 (3.6) 349 (2.8) 98 (1.7) 625 (3.0) 229 (1.7)
Hypertension 86 610 (48.4) 5682 (46.0) 2191 (38.4) 9285 (45.3) 5237 (39.1)
Depression 35 617 (19.9) 2543 (20.6) 1289 (22.6) 5102 (24.9) 3309 (24.7)
Mean (SD) body mass index (kg/m2):
 <18.5 737 (0.4) 97 (0.8) 54 (0.9) 123 (0.6) 66 (0.5)
 18.5-24.9 58 223 (32.5) 5227 (42.3) 2941 (51.6) 7942 (38.7) 5737 (42.9)
 25.0-29.9 76 492 (42.7) 4789 (38.8) 2187 (38.3) 8242 (40.2) 5714 (42.7)
 ≥30.0 43 524 (24.3) 2239 (18.1) 522 (9.2) 4211 (20.5) 1863 (13.9)
Alcohol drinker status:
 Never 5446 (3.0) 559 (4.5) 109 (1.9) 664 (3.2) 214 (1.6)
 Former 4537 (2.5) 427 (3.5) 192 (3.4) 547 (2.7) 300 (2.2)
 Current 168 993 (94.4) 11 366 (92.0) 5403 (94.7) 19 307 (94.1) 12 866 (96.2)
All variables globally significantly different between groups at P<0.001.
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and 806 (6.0%) of the participants who reported 
commuting by mixed mode cycling. This compared 
with injury in 7698 (4.3%) non-active commuters, 
541 (4.4%) commuters who walked, and 799 (3.9%) 
participants who commuted by mixed mode walking.
The incidence rates of injury per 1000 person years, 
show that cycling was associated with higher rates 
(fig 1, supplementary table s1). The cycling group 
experienced 8.06 events per 1000 person years versus 
4.96 events per 1000 person years in non-active 
commuters (P<0.001). Injury rates were also higher 
in mixed mode cycling commuters compared with 
non-active commuters (6.99 events per 1000 person 
years). Those who cycled further (either exclusively or 
as mixed mode) had a greater risk of injury (fig 1). In 
contrast, there was no evidence that greater commute 
distance was associated with higher risk of injury in 
other commuter groups (fig 1).
Multivariable analysis of injury
Using age and sex adjusted hazard ratios, commuters 
who exclusively cycled were at 67% higher risk of first 
injury than non-active commuters (supplementary 
table s1). Mixed mode cycling commuters were at 
47% higher risk. After adjusting for age, sex, and 
estimated hours spent commuting, the association 
was attenuated to a 33% higher risk among commuters 
who exclusively cycled (supplementary table s2).
After extensive adjustment, the association of 
cycling with injury remained strong whether those who 
exclusively commuted by cycling (hazard ratio 1.45, 
95% confidence interval 1.30 to 1.61) or by mixed 
mode cycling (1.39, 1.29 to 1.50) were considered (fig 
2, supplementary table s3) compared with non-active 
commuters. When those who commuted to work by 
cycling (exclusively or mixed mode) were compared 
with all other commuters, after adjustment those who 
incorporated cycling at all in their commute were at 
1.43-fold (95% confidence interval 1.34-fold to 1.52-
fold) increased risk of injury. Given the background rate 
of 4.93 injuries per 1000 person years in those who did 
not include cycling in their commute, the absolute risk 
difference was 2.59 first injuries per 1000 person years 
among cycling commuters.
Commuting by exclusively cycling and mixed 
mode cycling were associated with higher risk of 
appendicular, trunk, head or neck, and fracture 
injuries specifically (table 3). Among commuters who 
exclusively cycled, the association was stronger for 
head or neck injuries and for fractures (table 3).
Commuters were more likely to walk or cycle to work 
if the commute distance was five miles or less; 12% of 
commuters reported at least partly using a bicycle if 
their commute was five miles or less (supplementary 
table s3). Evidence was found that commute by 
cycling over larger distances was associated with 
higher risk of injury even after adjustment (fig 2, 
supplementary table s3). Both men and women were 
at higher risk of injury if they commuted by cycling, 
although the estimate was slightly stronger in men 
(supplementary table s4). No strong evidence was 
found of an interaction between residential location 
(urban/rural), or physical activity with commute 
mode and risk of injury. There was a trend towards 
a stronger association of cycling with injury in those 
with baseline assessment after 1 January 2010 
(supplementary table s4).
Exclusive commuting by cycling was strongly 
associated with injury related admissions to hospital 
of 1 day, 2-6 days, and 7 or more days, (supplementary 
table s5). Only 1211 (11.8%) of injuries in all 
commuters resulted in a hospital admission for 7 or 
more days, and the proportion was similar in exclusive 
cyclists (n=48, 12.1%). Commuting by mixed mode 
cycling was also associated with injuries in all lengths 
of hospital stay (supplementary table s5).
Multivariable analysis of transport incidents
The number of hospital admissions specifically as a 
result of transport incidents was strongly associated 
with commuting mode. Exclusive and mixed mode 
commuting by bicycle were associated with 3.42-
fold (3.00-fold to 3.90-fold) and 2.62-fold (2.37-
fold to 2.91-fold) higher risk (table 4). As an internal 
validation, commute by cycling was also strongly 
associated with hospital admissions specifically 
related to cycling transport incidents (table 4).
Table 2 | Baseline characteristics of participants (n=230 930) by incidence of injury. 
Values are numbers (percentages) unless stated otherwise
Characteristics
No injury 
(n=220 689)
≥1 injury  
(n=10 241)
Mean (SD) age (years) 52.4 (7.0) 53.3 (7.2)
Sex:
 Women 115 103 (52.2) 5127 (50.1)
 Men 105 586 (47.8) 5114 (49.9)
Ethnicity:
 White 209 393 (94.9) 9910 (96.8)
 Black 3431 (1.6) 82 (0.8)
 South Asian 3207 (1.5) 96 (0.9)
 Other 4658 (2.1) 153 (1.5)
Smoking status:
 Never 128 444 (58.2) 5631 (55.0)
 Former 69 622 (31.5) 3318 (32.4)
 Current 22 623 (10.3) 1292 (12.6)
Baseline cardiovascular disease 6131 (2.8) 395 (3.9)
Median (interquartile range) Townsend deprivation index −2.20 (−3.68, 0.26) −2.01 (−3.55, 0.63)
Longstanding illness 52 832 (23.9) 2941 (28.7)
Physical activity:
 Sedentary 25 808 (11.7) 1089 (10.6)
 Moderately active 157 117 (71.2) 6903 (67.4)
 Very active 37 764 (17.1) 2249 (22.0)
Previous cancer 12 153 (5.5) 635 (6.2)
Diabetes 7384 (3.3) 417 (4.1)
Hypertension 103 876 (47.1) 5129 (50.1)
Depression 45 885 (20.8) 1975 (19.3)
Body mass index (kg/m2):
 <18.5 1025 (0.5) 52 (0.5)
 18.5-24.9 76 493 (34.7) 3577 (34.9)
 25.0-29.9 93 138 (42.2) 4286 (41.9)
 ≥30.0 50 033 (22.7) 2326 (22.7)
Alcohol drinker status:
 Never 6708 (3.0) 284 (2.8)
 Former 5709 (2.6) 294 (2.9)
 Current 208 272 (94.4) 9663 (94.4)
All variables globally significantly different between groups at P<0.001, except cancer (P=0.003), alcohol drinker 
status (P=0.07), and body mass index category (P=0.83).
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Multivariable analysis of risk of cardiovascular 
disease, cancer, and mortality
When those who commuted to work by cycling 
(exclusively or mixed mode) were compared with 
all other commuters, after adjustment those who 
incorporated cycling in their commute showed 
a reduced risk of cardiovascular disease (hazard 
ratio 0.79, 95% confidence interval 0.69 to 0.90), 
first cancer diagnosis (0.89, 0.84 to 0.94), and all 
cause mortality (0.88, 0.78 to 1.00) and the similar 
trends were observed in exclusive and mixed mode 
cyclists separately (supplementary table 6). Given 
the background rate of 12.96 first cancers, 1.99 
cardiovascular disease events, and 2.41 deaths per 
1000 person years in those who did not include cycling 
in their commute, cyclists have an adjusted absolute 
risk difference of 1.53 fewer first cancers, 0.43 fewer 
cardiovascular disease events, and 0.27 fewer deaths 
per 1000 person years.
Discussion
Our results support the reported perception17 among 
the general public that cycling in the UK, specifically 
for commuting purposes, is associated with a higher 
risk of injuries. Although our study also showed that 
those who commuted by cycling had a lower risk of 
cardiovascular disease and cancer than non-active 
commuters, such health benefits will only be achieved 
by those who take up cycling. The risk of injury 
associated with cycling commuting needs to be taken 
seriously and a safer infrastructure provided if we are 
to address cycling dangers (both real and perceived) in 
the UK. This could help increase the uptake of cycling 
commuting with resulting benefits to health and the 
environment.
Widespread health advice from bodies such as 
the World Health Organization, NHS, and National 
Institute for Health and Care Excellence advocate 
increased physical activity in the general population 
to improve health,8 25 and active commuting has been 
suggested as one possible solution. The present data 
suggest that the higher risk of injury associated with 
cycle commuting is real, but seems to be outweighed 
by the health benefits. We show that commuting by 
bicycle in the UK is associated with a 45% higher risk 
of hospital admission for a first injury, independent of 
confounders including physical activity levels. This 
equates to 26 additional first injuries for 1000 people 
changing modes of commuting to include cycling 
in their commute for 10 years. Of these additional 
injuries, three would require hospital stays of a week 
or longer. This higher risk of injury is offset by the 
expected benefit of 15 fewer first cancers, four fewer 
cardiovascular disease events, and three fewer deaths. 
In line with this, one previous study has suggested a 
benefit:risk ratio of 77:1.26 Secondly, we also report 
that cycling longer distances was associated with a 
higher risk of injury. Thirdly, to consider injuries when 
the mode of commute was more likely attributable as 
the external cause of injury, we specifically investigated 
hospital admissions for injuries when the external 
cause was listed as a transport incident. We estimated 
that people who exclusively cycled to work were at 3.4-
fold higher risk of injury due to a transport incident, 
compared with non-active commuters.
Full cohort
  Non-active
  Walk
  Cycle
  Mixed mode: walk
  Mixed mode: cycle
≤5 mile commute
  Non-active
  Walk
  Cycle
  Mixed mode: walk
  Mixed mode: cycle
6-10 mile commute
  Non-active
  Walk
  Cycle
  Mixed mode: walk
  Mixed mode: cycle
≥11 mile commute
  Non-active
  Walk
  Cycle
  Mixed mode: walk
  Mixed mode: cycle
1 20.5 4
Hazard ratio
(95% CI)
*
*
Fig 2 | Adjusted hazard ratios (95% confidence intervals) for injury by commuting 
mode, in the full cohort and stratified by one way commute distance. *Insufficient 
data for walking commuters. Models adjusted for age, sex, ethnicity, Townsend 
deprivation index score, comorbidities (longstanding illness, diabetes, hypertension, 
cardiovascular disease, cancer, and depression), body mass index, smoking, alcohol 
drinker status, and five physical activity levels
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Fig 1 | Incidence rates (per 1000 person years) for first injury by commute mode and 
by commute distance. Data were insufficient to estimate injury rates for participants 
who exclusively walked more than five miles during a commute. Error bars are 95% 
confidence intervals. P values are tests for linear trend in rates across distance 
categories
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Implications of findings and wider context
Cycling might carry an excess risk of injury from being 
in a vulnerable physical position compared to falls 
from when someone is on foot. A review of empirical 
data, however, concluded that clearly marked bike 
specific road facilities were consistently shown to 
provide improved safety for cyclists, reducing injury or 
crash rates by about half compared with unmodified 
roads.27 In other work it is debated whether physical 
segregation of cycle lanes offers more effective 
protection than painted cycle lanes.28-30 Our research 
cannot make specific recommendations in this 
respect, but suggests a need for both local and central 
government to consider a wide range of options for 
improving cycling specific as well as general road 
safety, such as improved infrastructure including 
segregated cycling from main traffic flows, traffic 
calming, speed reductions, and improved training for 
all road users.28-35 In countries with a good cycling 
infrastructure, such as Denmark and the Netherlands, 
the risk of injuries from cycling are lower than in 
countries without such infrastructures.61 61 9 Perceived 
dangers represent a deterrent to cycling for many17 18 36 
and thus to realise the potential public health benefits 
of increased participation in cycling, an important 
public health need exists to improve road safety for 
cyclists in the UK. The present findings suggest that if 
the UK aims to increase participation in cycling as a 
commute mode (and for other journeys), making the 
journey safer would further improve the risk: benefit 
balance.
In this UK setting, commuters were more likely 
to cycle to work if the distance between home and 
workplace was relatively short (12% of commutes up 
to five miles involved cycling). For longer distances, 
motorised modes of transport were more common. 
Cyclists reported travelling more than 11 miles one way 
to work and would therefore be spending more time on 
the bicycle than shorter distance commuters, as shown 
by our analysis. A study by Mindell and colleagues19 
showed a higher risk of hospital admission from cycling 
(admissions per million hours’ use were 29 in men and 
28 in women) versus those for driving (admissions 
per million hours’ use 1.6 in men and 1.8 in women), 
but for cycling this included admissions linked with 
riskier competitive and leisure time cycling activities, 
so might overestimate the risks associated with 
commuting. Mindell and colleagues’ study advocated 
that this time spent “at risk” during a journey should 
be considered a potential confounder or effect modifier 
in the analysis.19 Our data do consider time spent at 
risk on commute journeys as part of the analysis. 
However, the reality for an individual considering how 
to commute to work is that the time spent at risk is of 
limited relevance to daily life. The commute must be 
made by one mode or another. Our data suggest that 
there is currently an associated higher risk of injury 
when commuting by cycling, but also a lower risk of 
poor health outcomes.
Strengths and limitations of this study
The strengths of this study include the size of the 
cohort and its breadth of phenotyping, which allowed 
extensive individual level adjustment for the covariate 
in the models. We also adjusted our models for self-
reported physical activity level, to attempt to account 
for non-commuting related activities that could have 
predisposed to higher risks of injury. Such approaches 
are often not possible using aggregate data or travel 
surveys. Weaknesses also require careful consideration. 
Because of the observational nature of the data 
caution is needed in inferring a causal association. 
As such, residual confounding is possible, but we 
show the association in several different models, and 
Table 3 | Adjusted hazard ratios of different incident injury types among participants 
(n=230 930) by commute mode
Injury type/location by commute 
mode No (%) injured
Adjusted hazard  ratio* 
(95 CI) P value
Appendicular:
 Non-active 5700 (3.2) 1 (ref)
 Walk 397 (3.2) 0.94 (0.85 to 1.05) 0.28
 Cycle 267 (4.7) 1.37 (1.21 to 1.56) <0.001
 Mixed mode: walk 595 (2.9) 0.91 (0.83 to 0.99) 0.03
 Mixed mode: cycle 556 (4.2) 1.33 (1.21 to 1.45) <0.001
Trunk:
 Non-active 763 (0.4) 1 (ref)
 Walk 48 (0.4) 0.90 (0.67 to 1.21) 0.51
 Cycle 46 (0.8) 1.53 (1.12 to 2.08) 0.007
 Mixed mode: walk 73 (0.4) 0.88 (0.69 to 1.12) 0.28
 Mixed mode: cycle 89 (0.7) 1.44 (1.15 to 1.81) 0.001
Head/neck:
 Non-active 1375 (0.8) 1 (ref)
 Walk 103 (0.8) 1.03 (0.84 to 1.26) 0.77
 Cycle 97 (1.7) 1.70 (1.37 to 2.10) <0.001
 Mixed mode: walk 142 (0.7) 0.93 (0.78 to 1.11) 0.43
 Mixed mode: cycle 171 (1.3) 1.53 (1.30 to 1.80) <0.001
Fractures:
 Non-active 4486 (2.5) 1 (ref)
 Walk 325 (2.6) 0.93 (0.83 to 1.05) 0.24
 Cycle 242 (4.2) 1.62 (1.42 to 1.86) <0.001
 Mixed mode: walk 521 (2.5) 0.98 (0.89 to 1.07) 0.64
 Mixed mode: cycle 455 (3.4) 1.43 (1.30 to 1.58) <0.001
*Adjusted for age, sex, ethnicity, Townsend deprivation index, comorbidities (longstanding illness, diabetes, 
hypertension, cardiovascular disease, cancer, and depression), body mass index, smoking, alcohol drinker 
status, and five physical activity levels.
Table 4 | Adjusted incident rate ratios of the number of transport related incidents and 
cycling related transport incidents by commuting mode among 230 930 UK Biobank 
commuters
Model and commute mode
Mean* (SD) events  
per 100 persons
Adjusted rate ratio†  
(95% CI) P value
Transport related incidents:
 Non-active 1.2 (11.6) 1 (ref)
 Walk 0.9 (10.0) 0.80 (0.66 to 0.97) 0.03
 Cycle 6.2 (27.3) 3.42 (3.00 to 3.90) <0.001
 Mixed mode: walk 0.9 (9.9) 0.79 (0.68 to 0.93) 0.003
 Mixed mode: cycle 4.2 (21.9) 2.62 (2.37 to 2.91) <0.001
Cycling related transport incidents (internal validation)
 Non-active 0.3 (6.2) 1 (ref)
 Walk 0.3 (5.7) 0.97 (0.70 to 1.37) 0.88
 Cycle 5.2 (24.6) 8.04 (6.80 to 9.51) <0.001
 Mixed mode: walk 0.3 (5.7) 0.92 (0.69 to 1.22) 0.56
 Mixed mode: cycle 3.0 (18.4) 5.52 (4.77 to 6.38) <0.001
Rate ratio for cycling incidents acts as a positive control among cycling commuters.
*Median for all categories is zero, mean and standard deviation per person multiplied by 100.
†Adjusted for sex, age, ethnicity, Townsend deprivation index, comorbidities (longstanding illness, diabetes, 
hypertension, cardiovascular disease, cancer, and depression), body mass index, smoking, alcohol drinker 
status, and five physical activity levels.
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also a modification by commute distance. Obtaining 
reliable data on cycling associated injuries is difficult. 
Statistics on cycling uptake and the consequences of 
cycling are often gained from and modelled on data 
from government transport data and surveys. As such, 
populations and exposures between different studies 
are often not comparable. Outcome ascertainment in 
such studies often relies on aggregated population 
level data, or data that might be related to the 
severity of incidents such as the UK STATS19 police 
reports.37 38 Our study used two different approaches, 
but will misclassify injuries that did not lead to 
hospital admission or death (in all commuting 
groups). As information on commuting was gathered 
by self-report, recall and misclassification bias are 
possible, although non-differential misclassification 
would bias results to the null. UK Biobank is known 
to be non-representative of the general UK population, 
being skewed towards better health and affluence. UK 
Biobank assessment centres were located in large cities 
so included few people who lived rurally, limiting our 
ability to check for interaction between commute mode 
and urban versus rural areas. We also did not have 
data to investigate local cycling infrastructure on the 
commute to work for individuals, but a stratified model 
for those recruited during and after 2010 (which may 
correspond with greater cycling infrastructure in some 
areas), did not identify any interaction. We only use 
hospital length of stay as a proxy for injury severity. We 
cannot make generalisations between the associations 
we observe and all commuting locations in the UK.
Conclusions and policy implications
Our study provides evidence that in the UK commuter 
cycling, compared with non-active modes, is associated 
with a higher risk of injury but lower risk of cancer, 
cardiovascular disease, and mortality. The perception 
among the general public that cycling carries a 
greater risk of injury than other modes of commuter 
transport is supported by evidence, although the 
health benefits are considerable. To change public 
perception of cycling as a viable commute mode and 
gain the associated health benefits, local and national 
infrastructure planners need to improve the safety for 
cycling commuters.
We thank the UK Biobank participants. UK Biobank was established 
by the Wellcome Trust medical charity, Medical Research Council, 
Department of Health, Scottish government, and North west Regional 
Development Agency. It has also had funding from the Welsh 
Assembly government and the British Heart Foundation. This research 
has been conducted using the UK Biobank resource under application 
number 7155.
Contributors: CW and CCM contributed equally to this work and are 
joint first authors. CW, CCM, FH, SG, JMRG, NS, JPP, and PW conceived 
and designed the study, advised on all statistical aspects, and 
interpreted the data. CW, CCM, FH, and PW did the statistical analysis. 
CW, CCM, and PW drafted the manuscript. All authors reviewed the 
manuscript and approved the final version to be published. All authors 
had full access to all the data in the study and take responsibility 
for the integrity of the data and the accuracy of the data analysis. 
CW, CCM, JPP, and PW are the guarantors. The corresponding author 
attests that all listed authors meet authorship criteria and that no 
others meeting the criteria have been omitted.
Funding: This study was supported by a grant from Chest, Heart, 
and Stroke Association Scotland (Res16/A165]) The research was 
designed, conducted, analysed, and interpreted by the authors 
entirely independently of the funding sources.
Competing interests: All authors have completed the ICMJE uniform 
disclosure form at www.icmje.org/coi_disclosure.pdf and declare: 
funding by a grant from Chest, Heart, and Stroke Association Scotland; 
JMRG, PW, CACM, NS, SRG, and JPP have received grant funding from 
British Cycling and HSBC UK for the Cycle Nation Project, a workplace 
based intervention to increase cycling participation, outside the 
submitted work; no other relationships or activities that could appear 
to have influenced the submitted work.
Ethical approval: UK Biobank received ethical approval from the 
North West Multi-centre Research Ethics Committee (REC reference: 
11/NW/03820). All participants gave written informed consent before 
enrolment in the study, which was conducted in accordance with the 
principles of the Declaration of Helsinki.
Data sharing: Researchers can apply to use the UK Biobank resource 
and access the data used. No additional data available.
The manuscript’s guarantors (CW, CCM, JPP, and PW) affirm that the 
manuscript is an honest, accurate, and transparent account of the 
study being reported; that no important aspects of the study have 
been omitted; and that any discrepancies from the study as planned 
(and, if relevant, registered) have been explained.
Dissemination to participants and related patient and public 
communities: There are no plans to disseminate the results of 
the research to study participants directly, but results will be made 
publicly available by open access publication, press release, and 
dissemination via social media and UK Biobank resources such as its 
website.
This is an Open Access article distributed in accordance with the 
Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, 
which permits others to distribute, remix, adapt, build upon this work 
non-commercially, and license their derivative works on different 
terms, provided the original work is properly cited and the use is non-
commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
1  Celis-Morales CA, Gray S, Petermann F. et al, Walking Pace Is 
Associated with Lower Risk of All-Cause and Cause-Specific 
Mortality. Med Sci Sports Exerc 2019;51:472-80. doi:10.1249/
MSS.0000000000001795 
2  Celis-Morales CA, Lyall DM, Steell L. et al, Associations of 
discretionary screen time with mortality, cardiovascular disease 
and cancer are attenuated by strength, fitness and physical activity: 
findings from the UK Biobank study. BMC Med 2018;16:77. 
doi:10.1186/s12916-018-1063-1 
3  Ding D, Lawson KD, Kolbe-Alexander TL, et al, Lancet Physical Activity 
Series 2 Executive Committee. The economic burden of physical 
inactivity: a global analysis of major non-communicable diseases. 
Lancet 2016;388:1311-24. doi:10.1016/S0140-6736(16)30383-X 
4  Lee IM, Shiroma EJ, Lobelo F, Puska P, Blair SN, Katzmarzyk PT, Lancet 
Physical Activity Series Working Group. Effect of physical inactivity 
on major non-communicable diseases worldwide: an analysis of 
burden of disease and life expectancy. Lancet 2012;380:219-29. 
doi:10.1016/S0140-6736(12)61031-9 
5  Physical Inactivity and Sedentary Behaviour Report 2017. Foundation 
BH. 2017. https://www.bhf.org.uk/informationsupport/publications/
statistics/physical-inactivity-report-2017 (accessed 1st Nov 2019).
6  Pucher J, Buehler R, Bassett DR, Dannenberg AL. Walking and cycling to 
health: a comparative analysis of city, state, and international data. Am 
J Public Health 2010;100:1986-92. doi:10.2105/AJPH.2009.189324 
7  Bassett DRJr, Pucher J, Buehler R, Thompson DL, Crouter SE. Walking, 
cycling, and obesity rates in Europe, North America, and Australia. J 
Phys Act Health 2008;5:795-814. doi:10.1123/jpah.5.6.795 
8  Walking and cycling: local measures to promote walking and cycling 
as forms of travel or recreation. NICE. 2012. www.nice.org.uk/
guidance/ph41 (accessed 1st Nov 2019).
9  Audrey S, Procter S, Cooper AR. The contribution of walking to work to 
adult physical activity levels: a cross sectional study. Int J Behav Nutr 
Phys Act 2014;11:37. doi:10.1186/1479-5868-11-37 
10  Blond MB, Rosenkilde M, Gram AS. et al, How does 6 months of active 
bike commuting or leisure-time exercise affect insulin sensitivity, 
cardiorespiratory fitness and intra-abdominal fat? A randomised 
controlled trial in individuals with overweight and obesity. Br J Sports 
Med 2019;53:1183-92. doi:10.1136/bjsports-2018-100036 
11  Celis-Morales CA, Lyall DM, Welsh P. et al, Association between 
active commuting and incident cardiovascular disease, cancer, 
and mortality: prospective cohort study. BMJ 2017;357:j1456. 
doi:10.1136/bmj.j1456 
12  Hu G, Jousilahti P, Borodulin K. et al, Occupational, commuting and 
leisure-time physical activity in relation to coronary heart disease 
among middle-aged Finnish men and women. Atherosclerosis 
2007;194:490-7. doi:10.1016/j.atherosclerosis.2006.08.051 
 o
n
 12 M
arch 2020 at University of G
lasgow. Protected by copyright.
http://www.bmj.com/
BM
J: first published as 10.1136/bmj.m336 on 11 March 2020. Downloaded from 
RESEARCH
No commercial reuse: See rights and reprints http://www.bmj.com/permissions Subscribe: http://www.bmj.com/subscribe
13  Hu G, Tuomilehto J, Borodulin K, Jousilahti P. The joint associations of 
occupational, commuting, and leisure-time physical activity, and the 
Framingham risk score on the 10-year risk of coronary heart disease. 
Eur Heart J 2007;28:492-8. doi:10.1093/eurheartj/ehl475 
14  Hou L, Ji B-T, Blair A, Dai Q, Gao YT, Chow WH. Commuting 
physical activity and risk of colon cancer in Shanghai, China. Am J 
Epidemiol 2004;160:860-7. doi:10.1093/aje/kwh301 
15  Hu G, Qiao Q, Silventoinen K. et al, Occupational, commuting, and 
leisure-time physical activity in relation to risk for Type 2 diabetes in 
middle-aged Finnish men and women. Diabetologia 2003;46:322-9. 
doi:10.1007/s00125-003-1031-x 
16  Pucher J, Buehler R. Making Cycling Irresistible: Lessons from The 
Netherlands, Denmark and Germany. Transp Rev 2008;28:495-528. 
doi:10.1080/01441640701806612
17  British Social Attitudes Survey 2015: Public attitudes towards 
transport. Department for transport. 2017. https://assets.
publishing.service.gov.uk/government/uploads/system/uploads/
attachment_data/file/586193/british-social-attitudes-survey-2015.
pdf (accessed 1st Nov 2019).
18  Fraser SDS, Lock K. Cycling for transport and public health: a 
systematic review of the effect of the environment on cycling. Eur J 
Public Health 2011;21:738-43. doi:10.1093/eurpub/ckq145 
19  Mindell JS, Leslie D, Wardlaw M. Exposure-based, ‘like-for-like’ 
assessment of road safety by travel mode using routine health data. 
PLoS One 2012;7:e50606. doi:10.1371/journal.pone.0050606 
20  Gill J, Baker G, Broadfoot S, et al. Confidence to ride. Confidence to 
invest - evidence review. 2019. https://www.britishcycling.org.uk/
zuvvi/media/bc_files/campaigning/2019/Glasgow_Report_digital_
single_pages_FINAL.pdf (accessed 1st Nov 2019).
21  Golbuff L, Aldred R, UEL Sustainable Mobilities Research Group. 
Cycling policy in the UK. A historical and thematic overview. 2011 
http://rachelaldred.org/wp-content/uploads/2012/10/cycling-
review1.pdf (accessed 1st Nov 2019).
22  Transport Scotland. Cycling by design. 2010 https://www.transport.
gov.scot/media/14173/cycling_by_design_2010__rev_1__
june_2011_.pdf (accessed 1st Nov 2019).
23  Department for Transport. Cycling and walking investment strategy. 
2016 https://assets.publishing.service.gov.uk/government/uploads/
system/uploads/attachment_data/file/512895/cycling-and-
walking-investment-strategy.pdf (accessed 1st Nov 2019).
24  Hilbe JM. Modeling Count Data. 2014 Cambridge. Cambridge 
University Press, 2014.
25  The global action plan on physical activity 2018-2030. WHO. 2018. 
https://www.who.int/ncds/prevention/physical-activity/gappa/
action-plan (accessed 1st Nov 2019).
26  Rojas-Rueda D, de Nazelle A, Tainio M, Nieuwenhuijsen MJ. 
The health risks and benefits of cycling in urban environments 
compared with car use: health impact assessment study. 
BMJ 2011;343:d4521. doi:10.1136/bmj.d4521 
27  Reynolds CCO, Harris MA, Teschke K, Cripton PA, Winters M. The 
impact of transportation infrastructure on bicycling injuries and 
crashes: a review of the literature. Environ Health 2009;8:47. 
doi:10.1186/1476-069X-8-47 
28  Lusk AC, Furth PG, Morency P, Miranda-Moreno LF, Willett WC, 
Dennerlein JT. Risk of injury for bicycling on cycle tracks versus in the 
street. Inj Prev 2011;17:131-5. doi:10.1136/ip.2010.028696 
29  Lusk AC, Morency P, Miranda-Moreno LF, Willett WC, Dennerlein 
JT. Bicycle guidelines and crash rates on cycle tracks in the United 
States. Am J Public Health 2013;103:1240-8. doi:10.2105/
AJPH.2012.301043 
30  Thomas B, DeRobertis M. The safety of urban cycle tracks: a review 
of the literature. Accid Anal Prev 2013;52:219-27. doi:10.1016/j.
aap.2012.12.017 
31  Teschke K, Harris MA, Reynolds CCO. et al, Route infrastructure and 
the risk of injuries to bicyclists: a case-crossover study. Am J Public 
Health 2012;102:2336-43.
32  Marshall W, Ferenchak N. Why cities with high bicycling rates 
are safer for all road users. J Transp Health 2019;13:100539. 
doi:10.1016/j.jth.2019.03.004.
33  Morrison CN, Thompson J, Kondo MC, Beck B. On-road bicycle lane 
types, roadway characteristics, and risks for bicycle crashes. Accid 
Anal Prev 2019;123:123-31. doi:10.1016/j.aap.2018.11.017 
34  Zangenehpour S, Strauss J, Miranda-Moreno LF, Saunier N. Are 
signalized intersections with cycle tracks safer? A case-control study 
based on automated surrogate safety analysis using video data. 
Accid Anal Prev 2016;86:161-72. doi:10.1016/j.aap.2015.10.025 
35  Grundy C, Steinbach R, Edwards P, Green J, Armstrong B, Wilkinson 
P. Effect of 20 mph traffic speed zones on road injuries in 
London, 1986-2006: controlled interrupted time series analysis. 
BMJ 2009;339:b4469. doi:10.1136/bmj.b4469 
36  Iwińska K, Blicharska M, Pierotti L, Tainio M, de Nazelle A. 
Cycling in Warsaw, Poland - Perceived enablers and barriers 
according to cyclists and non-cyclists. Transp Res Part A Policy 
Pract 2018;113:291-301. doi:10.1016/j.tra.2018.04.014 
37  Aldred R, Goodman A, Gulliver J, Woodcock J. Cycling injury risk 
in London: A case-control study exploring the impact of cycle 
volumes, motor vehicle volumes, and road characteristics including 
speed limits. Accid Anal Prev 2018;117:75-84. doi:10.1016/j.
aap.2018.03.003 
38  Woodcock J, Tainio M, Cheshire J, O’Brien O, Goodman A. Health 
effects of the London bicycle sharing system: health impact 
modelling study. BMJ 2014;348:g425. doi:10.1136/bmj.g425
Supplementary material: additional tables 1-6
 o
n
 12 M
arch 2020 at University of G
lasgow. Protected by copyright.
http://www.bmj.com/
BM
J: first published as 10.1136/bmj.m336 on 11 March 2020. Downloaded from 
